Genetic susceptibility to radiation-related differentiated thyroid cancers: a systematic review of literature.


Journal

Endocrine-related cancer
ISSN: 1479-6821
Titre abrégé: Endocr Relat Cancer
Pays: England
ID NLM: 9436481

Informations de publication

Date de publication:
10 2019
Historique:
received: 05 08 2019
accepted: 27 08 2019
pubmed: 3 9 2019
medline: 14 7 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

The first study establishing exposure to ionizing radiations (IRs) as a risk factor for differentiated thyroid cancer (DTC) was published 70 years ago. Given that radiation exposure causes direct DNA damage, genetic alterations in the different DNA repair mechanisms are assumed to play an important role in long-term IR-induced DNA damage prevention. Individual variations in DNA repair capacity may cause different reactions to damage made by IR exposure. The aim of this review is to recapitulate current knowledge about constitutional genetic polymorphisms found to be significantly associated with DTC occurring after IR exposure. Studies were screened online using electronic databases - only fully available articles, and studies performed among irradiated population or taking radiation exposure as adjustment factors and showing significant results are included. Nine articles were identified. Ten variants in/near to genes in six biological pathways, namely thyroid activity regulations, generic transcription, RET signaling, ATM signaling and DNA repair pathways were found to be associated with radiation-related DTC in these studies. Only seven variants were found to be in interaction with IR exposure in DTC risk. Most of these variants are also associated to sporadic DTC and are not specific to IR-related DTC. In the published studies, no data on children treated with radiotherapy is described. In conclusion, more studies carried out on larger cohorts or on case-control studies with well-documented individual radiation dose estimations are needed to get a comprehensive picture of genetic susceptibility factors involved in radiation-related DTC.

Identifiants

pubmed: 31476737
doi: 10.1530/ERC-19-0321
pii: ERC-19-0321
doi:
pii:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

R583-R596

Auteurs

Monia Zidane (M)

INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Radiation Epidemiology Group, Villejuif, France.
Université Paris-Sud Orsay, Île-de-France, France.
Gustave Roussy, Villejuif, France.

Jean-Baptiste Cazier (JB)

Institute of Cancer and Genomic Sciences, Centre for Computational Biology, University of Birmingham, Birmingham, UK.

Sylvie Chevillard (S)

CEA, Direction de la Recherche Fondamentale, Institut de Biologie François Jacob, iRCM, SREIT, Laboratoire de Cancérologie Expérimentale (LCE), Université Paris-Saclay, Fontenay-aux-Roses, France.

Catherine Ory (C)

CEA, Direction de la Recherche Fondamentale, Institut de Biologie François Jacob, iRCM, SREIT, Laboratoire de Cancérologie Expérimentale (LCE), Université Paris-Saclay, Fontenay-aux-Roses, France.

Martin Schlumberger (M)

Université Paris-Sud Orsay, Île-de-France, France.
Gustave Roussy, Villejuif, France.
UMR 8200 CNRS, Villejuif, France.

Corinne Dupuy (C)

Université Paris-Sud Orsay, Île-de-France, France.
Gustave Roussy, Villejuif, France.
UMR 8200 CNRS, Villejuif, France.

Jean-François Deleuze (JF)

Centre National de Recherche en Génomique Humaine, CEA, Evry, France.

Anne Boland (A)

Centre National de Recherche en Génomique Humaine, CEA, Evry, France.

Nadia Haddy (N)

INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Radiation Epidemiology Group, Villejuif, France.
Université Paris-Sud Orsay, Île-de-France, France.
Gustave Roussy, Villejuif, France.

Fabienne Lesueur (F)

Institut Curie, Paris, France.
PSL Research University, Paris, France.
INSERM, U900, Paris, France.
Mines Paris Tech, Fontainebleau, France.

Florent de Vathaire (F)

INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Radiation Epidemiology Group, Villejuif, France.
Université Paris-Sud Orsay, Île-de-France, France.
Gustave Roussy, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH